Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,242,000 | 14,593,000 | 11,304,000 | 5,579,000 | 6,841,000 |
| Marketable Securities | 447,000 | N/A | 50,000 | 40,000 | 252,000 |
| Receivables | 10,278,000 | 11,381,000 | 11,642,000 | 11,366,000 | 10,349,000 |
| Inventories | 6,109,000 | 6,244,000 | 6,469,000 | 6,510,000 | 6,358,000 |
| Other current assets | 8,706,000 | 8,143,000 | 8,740,000 | 7,950,000 | 8,368,000 |
| TOTAL | $38,782,000 | $40,361,000 | $38,205,000 | $31,445,000 | $32,168,000 |
| Non-Current Assets | |||||
| PPE Net | 23,779,000 | 23,446,000 | 23,221,000 | 23,045,000 | 23,051,000 |
| Investments And Advances | 463,000 | 575,000 | 357,000 | 280,000 | 252,000 |
| Intangibles | 38,038,000 | 38,707,000 | 38,145,000 | 38,753,000 | 39,208,000 |
| Other Non-Current Assets | 16,044,000 | 14,443,000 | 12,702,000 | 12,326,000 | 11,996,000 |
| TOTAL | $78,324,000 | $77,171,000 | $74,425,000 | $74,404,000 | $74,507,000 |
| Total Assets | $117,106,000 | $117,532,000 | $112,630,000 | $105,849,000 | $106,675,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,079,000 | 3,586,000 | 3,519,000 | 3,514,000 | 3,922,000 |
| Accrued Expenses | 15,694,000 | 16,539,000 | 14,712,000 | 14,102,000 | 15,766,000 |
| TOTAL | $28,420,000 | $29,586,000 | $26,060,000 | $25,099,000 | $25,694,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 34,462,000 | 34,982,000 | 34,717,000 | 31,142,000 | 33,683,000 |
| Other Non-Current Liabilities | 6,464,000 | 7,536,000 | 7,323,000 | 8,257,000 | 8,792,000 |
| TOTAL | $42,314,000 | $43,386,000 | $42,922,000 | $40,326,000 | $43,346,000 |
| Total Liabilities | $70,734,000 | $72,972,000 | $68,982,000 | $65,425,000 | $69,040,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,526,036 | 2,529,636 | 2,534,809 | 2,532,806 | 2,532,644 |
| Common Shares | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 |
| Retained earnings | 63,069,000 | 61,384,000 | 60,187,000 | 56,697,000 | 53,895,000 |
| Other shareholders' equity | -4,886,000 | -5,313,000 | -5,295,000 | -5,214,000 | -5,107,000 |
| TOTAL | $46,372,000 | $44,560,000 | $43,648,000 | $40,424,000 | $37,635,000 |
| Total Liabilities And Equity | $117,106,000 | $117,532,000 | $112,630,000 | $105,849,000 | $106,675,000 |